CGEM — Cullinan Therapeutics, Inc. stock price, charts and financials

QT91Cullinan Therapeutics, Inc.

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
21.08
-0.28-1.31%
OverviewShort InterestFilings
CGEMQT91Cullinan Therapeutics, Inc.·NASDAQ
21.08-1.31%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 14, 20268-KCurrent report
Sep 10, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 20264Statement of changes in beneficial ownership
Aug 13, 20268-KCurrent report
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 07, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 16, 20268-KCurrent report
Jun 10, 20268-KCurrent report
Jun 08, 20268-KCurrent report
May 18, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 20268-KCurrent report
May 07, 202610-QQuarterly report
#1 / 25 of 372
Page
▼
/ 15